Passive Immunization with LINGO-1 Polyclonal Antiserum Afforded Neuroprotection and Promoted Functional Recovery in a Rat Model of Spinal Cord Injury

被引:21
作者
Lv, Jun [1 ]
Xu, Ru-xiang [1 ]
Jiang, Xiao-dan [1 ]
Lu, Xin [2 ]
Ke, Yi-quan [1 ]
Cai, Ying-qian [1 ]
Du, Mou-xuan [1 ]
Hu, Changchen [1 ]
Zou, Yu-xi [1 ]
Qin, Ling-sha [1 ]
Zeng, Yan-jun [3 ]
机构
[1] So Med Univ, Zhujiang Hosp, Neurosurg Inst Guangdong, Dept Neurosurg, Guangzhou 510282, Guangdong, Peoples R China
[2] So Med Univ, Zhujiang Hosp, Dept Endocrinol, Guangzhou 510282, Guangdong, Peoples R China
[3] Beijing Univ Technol, Biomech & Med Informat Inst, Beijing, Peoples R China
关键词
LINGO-1; Passive immunization; Spinal cord injury; RhoA; Neuron apoptosis; Functional recovery; CENTRAL-NERVOUS-SYSTEM; AXONAL REGENERATION; INHIBITOR; RECEPTOR; RHO;
D O I
10.1159/000290043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
LINGO-1 (leucine-rich repeat and Ig domain-containing, Nogo receptor-interacting protein) is an important component of the NgR receptor complex involved in RhoA activation and axon regeneration. The authors report on passive immunization with LINGO-1 polyclonal antiserum, a therapeutic approach to overcome NgR-mediated growth inhibition after spinal cord injury (SCI). The intrathecally administered high-titer rabbit-derived antiserum can be detected around the injury site within a wide time window; it blocks LINGO-1 in vivo with high molecular specificity. In this animal model, passive immunization with LINGO-1 antiserum significantly decreased RhoA activation and increased neuronal survival. Adult rats immunized in this manner show recovery of certain hindlimb motor functions after dorsal hemisection of the spinal cord. Thus, passive immunotherapy with LINGO-1 polyclonal antiserum may represent a promising repair strategy following acute SCI. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:270 / 278
页数:9
相关论文
共 13 条
[1]   Central nervous system and non-central nervous system antigen vaccines exacerbate neuropathology caused by nerve injury [J].
Ankeny, Daniel P. ;
Popovich, Phillip G. .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2007, 25 (07) :2053-2064
[2]   Axonal growth therapeutics: regeneration or sprouting or plasticity? [J].
Cafferty, William B. J. ;
Mcgee, Aaron W. ;
Strittmatter, Stephen M. .
TRENDS IN NEUROSCIENCES, 2008, 31 (05) :215-220
[3]   Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system [J].
Dubreuil, CI ;
Winton, MJ ;
McKerracher, L .
JOURNAL OF CELL BIOLOGY, 2003, 162 (02) :233-243
[4]   A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord [J].
Huang, DW ;
McKerracher, L ;
Braun, PE ;
David, S .
NEURON, 1999, 24 (03) :639-647
[5]   LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury [J].
Ji, Benxiu ;
Li, Mingwei ;
Wu, Wu-Tian ;
Yick, Leung-Wah ;
Lee, Xinhua ;
Shao, Zhaohui ;
Wang, Joy ;
So, Kwok-Fai ;
McCoy, John M. ;
Pepinsky, R. Blake ;
Mi, Sha ;
Relton, Jane K. .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2006, 33 (03) :311-320
[6]  
Kubo T, 2007, CURR PHARM DESIGN, V13, P2493
[7]   Monoclonal antibodies come of age [J].
Ledford, Heidi .
NATURE, 2008, 455 (7212) :437-437
[8]   LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex [J].
Mi, S ;
Lee, X ;
Shao, ZH ;
Thill, G ;
Ji, BX ;
Relton, J ;
Levesque, M ;
Allaire, N ;
Perrin, S ;
Sands, B ;
Crowell, T ;
Cate, RL ;
McCoy, JM ;
Pepinsky, RB .
NATURE NEUROSCIENCE, 2004, 7 (03) :221-228
[9]   LINGO-1 and its role in CNS repair [J].
Mi, Sha ;
Sandrock, Alfred ;
Miller, Robert H. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (10) :1971-1978
[10]   A NOVEL ROLE FOR MYELIN-ASSOCIATED GLYCOPROTEIN AS AN INHIBITOR OF AXONAL REGENERATION [J].
MUKHOPADHYAY, G ;
DOHERTY, P ;
WALSH, FS ;
CROCKER, PR ;
FILBIN, MT .
NEURON, 1994, 13 (03) :757-767